Literature DB >> 1686022

Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection.

S K Kundu1, T C Merigan.   

Abstract

Profiles of CD8+CD11+ T suppressor cells, human immunodeficiency virus (HIV)-env-specific cytotoxic T-lymphocyte (CTL) activities, and natural killer (NK) cell activity were studied in 12 asymptomatic untreated HIV-infected patients. These patients were followed for 4-7 months. NK activity, HIV-env-specific CTL activities mediated by CD4+, CD8+ T cells and CD8+CD11+ T-suppressor cell number remained stable in seven patients during the study period. Alternatively, NK and HIV-specific CTL activities decreased and CD8+CD11+ cell number increased in five patients whose CD4+ T-cell number fell, and in four of these five patients serum p24 antigen level increased, and they developed minor clinical signs of disease progression during the study period. CD8+CD11+ cells are present in higher percentage (10-45% of peripheral blood mononuclear cells) in these HIV-infected patients as compared to those in normal individuals (3-5%). Our results suggest that CD8+CD11+ cells, NK, and HIV-specific cytotoxic activities may be helpful in monitoring prognosis of HIV infection. These observations also suggest that CD8+CD11+ cells may play an important role in the failure of host immune defences against HIV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686022      PMCID: PMC1384761     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes.

Authors:  P Joly; J M Guillon; C Mayaud; F Plata; I Theodorou; M Denis; P Debre; B Autran
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

2.  Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.

Authors:  S Koenig; P Earl; D Powell; G Pantaleo; S Merli; B Moss; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.

Authors:  A Hoffenbach; P Langlade-Demoyen; G Dadaglio; E Vilmer; F Michel; C Mayaud; B Autran; F Plata
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

4.  Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome.

Authors:  D E Lewis; J M Puck; G F Babcock; R R Rich
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

5.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones.

Authors:  K K Sethi; H Näher; I Stroehmann
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

7.  Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.

Authors:  J V Giorgi; P G Nishanian; I Schmid; L E Hultin; H L Cheng; R Detels
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

8.  Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.

Authors:  M Clerici; D R Lucey; R A Zajac; R N Boswell; H M Gebel; H Takahashi; J A Berzofsky; G M Shearer
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

9.  Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.

Authors:  Y Riviere; F Tanneau-Salvadori; A Regnault; O Lopez; P Sansonetti; B Guy; M P Kieny; J J Fournel; L Montagnier
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Suppressor T lymphocytes from lepromatous leprosy skin lesions.

Authors:  R L Modlin; V Mehra; L Wong; Y Fujimiya; W C Chang; D A Horwitz; B R Bloom; T H Rea; P K Pattengale
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

View more
  8 in total

1.  Heterogeneity of cytokine functions in HIV infection.

Authors:  S K Kundu; T C Merigan
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?

Authors:  D R Bainbridge; M W Lowdell; I M Hannet; K W Strauss; A Karpas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-07-29       Impact factor: 6.237

3.  HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine.

Authors:  T Tsuji; J Fukushima; K Hamajima; N Ishii; I Aoki; H Bukawa; Y Ishigatsubo; K Tani; T Okubo; M E Dorf; K Okuda
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 4.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates.

Authors:  M J Irwin; L S Laube; V Lee; M Austin; S Chada; C G Anderson; K Townsend; D J Jolly; J F Warner
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset.

Authors:  B J Willett; M J Hosie; J J Callanan; J C Neil; O Jarrett
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

7.  Relationship of HIV-1 provirus load, CD8+ CD11+ T cells and HIV-1 envelope-specific cytotoxic T lymphocytes in HIV-infected asymptomatic offients.

Authors:  S K Kundu; T C Merigan
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

8.  Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.

Authors:  S K Kundu; D Katzenstein; L E Moses; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.